Hepatitis B and C viruses IVD
The purpose of this document is to provide manufacturers and sponsors with guidance on the Therapeutic Goods Administration’s (TGA) expectations concerning clinical performance requirements (i.e. clinical sensitivity and specificity) and risk mitigations for in vitro diagnostic medical devices (IVDs) intended to be used as self-tests for hepatitis B virus (HBV) and hepatitis C virus (HCV). ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- fifth national aboriginal and torres strait islander blood
- note centers for disease control and prevention
- strategies for inactivation of viruses bacteria in blood
- infection with high pathogenicity avian influenza viruses
- hepatitis b and c viruses ivd
- blood borne virus occupational risk exposure management
- safe working with blood bodily fluids and human tissue ucl